Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations (Unaudited)

v3.19.1
Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Mar. 31, 2019
Mar. 31, 2018
Operating expenses:        
Research and development $ 1,275,948 $ 1,666,902 $ 3,954,848 $ 1,983,372
General and administrative 1,426,056 883,009 4,637,370 3,003,980
Total Operating Expenses 2,702,004 2,549,911 8,592,218 4,987,352
Loss from Operations (2,702,004) (2,549,911) (8,592,218) (4,987,352)
Other income (expenses):        
Change in fair value of derivative liabilities (254,862) (54,634) 80,542
Loss on extinguishment of debt (3,774,468)
Interest income (expense), net 15,939 (397,111) (774,148) (706,460)
Other income 2,350
Total other income (expenses) 15,939 (651,973) (4,603,250) (623,568)
Net loss $ (2,686,065) $ (3,201,884) $ (13,195,468) $ (5,610,920)
Loss per common share - basic and diluted $ (0.09) $ (0.26) $ (0.58) $ (0.45)
Weighted average number of common shares outstanding - basic and diluted 30,037,971 12,547,620 22,670,534 12,542,678